Stock BGLC BIONEXUS GENE LAB CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioNexus Gene Lab Corp.

Equities

BGLC

US0906282076

Real-time Estimate Cboe BZX
Other stock markets
 11:20:08 2024-05-14 EDT 		5-day change 1st Jan Change
0.593 USD +2.22% Intraday chart for BioNexus Gene Lab Corp. -2.21% +10.38%
04-16 BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-29 BioNexus Gene Lab Corp. Provides Information to Shareholders CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
AQ
BioNexus Gene Lab : Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Form 8-K
PU
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioNexus Gene Lab : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
BioNexus Gene Lab Corp. Provides Information to Shareholders
CI
Certain Common Stock of BioNexus Gene Lab Corp. are subject to a Lock-Up Agreement Ending on 18-JAN-2024.
CI
Soo Kow Lai Provides Information to Shareholders of BioNexus Gene Lab Corp
CI
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Bionexus Gene Lab Corp. Announces Resignation of Wei Li Leong as Chief Financial Officer
CI
BioNexus Gene Lab Names Chi Yuen Leong as CEO
MT
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as the Chief Executive Officer
CI
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as A Director
CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Chief Executive Officer
CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Board of Directors
CI
BioNexus Gene Lab Corp. Announces Executive Changes
CI
Top Premarket Gainers
MT
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
BioNexus Gene Lab Raises $5.8 Million from Public Share Offering
MT
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
AQ
BioNexus Gene Lab Corp.(NasdaqCM:BGLC) added to NASDAQ Composite Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BGLC Stock
  4. News BioNexus Gene Lab Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW